Cytokines that regulate autoimmune myocarditis

Swiss Medical Weekly

Volumn 132, Issue 29-30, 2002, Pages 408-413

  Kurrer, Michael O ^a   Kopf, Manfred ^a   Penninger, Josef M ^a   Eriksson, Urs ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Autoimmunity; Chemokines; Cytokines; Experimental autoimmune myocarditis; Interferon ; Interleukin 10; Interleukin 12; Interleukin 4; Myocarditis; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MYOSIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOMYOPATHY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; GENE TARGETING; HEART FAILURE; HUMAN; IMMUNE RESPONSE; MYOCARDITIS; NONHUMAN; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

EID: 0037183370     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994;72(Suppl.):S30-4.
2. Martino TA, Liu P, Sole M-J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994;74:182-8.
3. Caforio ALP, Goldmann JH, Haven A J, Baig KM, McKenna W. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996;54:157-63.
4. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 1999;99:1091-100.
5. Luther SA, Cyster JG. Chemokines as regulators of T-cell differentiation. Nat Immunol 2001;2:102-7.
6. Penninger JM, Pummerer C, Liu P, Neu N, Bachmaier K. Cellular and molecular mechanisms of murine autoimmune myocarditis. APMIS 1997;105:1-13.
7. Neu N, Rose NR, Beisel KW, Herskovitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630-36.
8. Bachmaier K, Neu N, de-la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335-9
9. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998;274:R577-R595.
10. Bachmaier K, Pummerer C, Kozieradzki I, Pfeffer K, Mak TW, Neu N, et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997;95:655-61.
11. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998;97:1375-81.
12. Yokoseki O, Suzuki J, Kitabayashi H, Watanabe N, Wada Y, et al. Cis element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 2001;89:899-906.
13. Kubota T, Bonoutas GS, Miyagishama M, Kadokami T, Sanders VJ, Bruton C, et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 2000;101:2518-25.
14. Fuse K, Kodama M, Hanawa H, Okura Y, Ito M, Shiono T, et al. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin Exp Immunol 2001;124:346-52.
15. Toyozaki T, Saito T, Shiraishi H, Tsukamato Y, Takano H, Nagai T, et al. Macrophage inflammatory protein-1 alpha relates to the recruitment of inflammatory cells in myosin-induced autoimmune myocarditis in rats. Lab Invest 2001;81(7):929-36
16. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995;269(5230):1583-5
17. Falcone M, Sarvetnick N. Cytokines that regulate autoimmune responses. Curr Opin Immunol 1999;11:670-76.
18. Metcalf D, Di Rago L, Mifsud A, Hartley L, Alexander WS. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-γ and lacking the SOCS-1 gene. Proc Natl Acad Sci 2000;97:9174-9.
19. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M. Dual role of the IL-12/IFN-γ axis in the development of myocarditis: Induction by IL-12 and protection by IFN-γ. J Immunol 2001;167:5464-9.
20. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, et al. Experimental autoimmune myocarditis in A/J mice is an Interleukin-4 dependent disease with a Th2 phenotype. Am J Pathol 2001;159:193-203.
21. Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U. Lethal autoimmune myocarditis in IFN-γ receptor deficient mice: Enhanced disease severity by impaired iNOS induction. Circulation 2001;96:585-91.
22. Afanasyeva M, Wang Y, Kaya Z, Stafford, EA, Dohmen KM, Sadighi Akha AA, et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001;104:3145-51.
23. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000;6:693-7.
24. Cunningham MW. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol 2001;159(1):5-12.
25. Gately M, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interl eukin-12-receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
26. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper cells in rats. Circ Res 1998;82:1035-42.
27. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin and the Interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
28. Nakano A, Matsumori A, Kawamoto S, Tahara H, Yamato E, Sasayama S, et al. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001;12:1289-1297
29. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, et al. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001;104:1098-100.
30. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, et al. A critical role for IL-10 in the induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002;168:1552-6.
31. Wang Y, Afanasyeva M, Hill SL, Kaya Z, Rose NR. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J Am Coll Cardiol 2000;36:1992-9.
32. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - Natural history and treatment. N Engl J Med 1997;336:1860-6.
33. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
34. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.